Skip to content
LookupMeds

Active ingredient

Bevacizumab

15 finished FDA listings contain Bevacizumab as their only active ingredient.

See all listingsCompare with another medication

FDA NDC Directory

Ingredient names as written by FDA
BEVACIZUMAB, BEVACIZUMAB-ADCD, BEVACIZUMAB-BVZR, BEVACIZUMAB-MALY
Dosage forms
Injection, Injection, Solution
Routes
Intravascular, Intravenous, Intravitreal
Manufacturers / labelers
8
Strengths listed
1.25 mg/1 · 100 mg/4ml · 25 mg/ml · 400 mg/16ml
Brand names in FDA listings
Alymsys, Avastin, Jobevne, Lytenava, Mvasi, Vegzelma, Zirabev

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 253337

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
BLA 125085GENENTECH2004-02-262
BLA 761028AMGEN INC2017-09-142
BLA 761099PFIZER INC2019-06-272
BLA 761231AMNEAL PHARMS LLC2022-04-134
BLA 761268CELLTRION2022-09-272
BLA 761175BIOCON BIOLOGICS INC2025-04-092
BLA 761320OUTLOOK THERAPEUTICS, INC.2026-07-241

Official labeling on DailyMed

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.